Long-acting lipoglycopeptides are as effective as standard-of-care antibiotics in treating serious bacterial infections in ...

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

Veterinarians often treat these infections with antibiotics, but over time, this widespread use contributes to antimicrobial ...

Many important antibiotics are becoming less effective against bacterial infections, as bacteria continue to evolve, gaining ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

More information: Jan Hermann et al, Long‐Term Pulmonary Sequelae 5–14 Years After Protracted Bacterial Bronchitis in Early Childhood, Pediatric Pulmonology (2025). DOI: 10.1002/ppul.71111 ...

Antibiotics area great way to combat illnesses, helping people take effective measures against diseases. However, they are ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they ...

Bacteria are behind a variety of diseases, from strep to staph to pneumonia and meningitis, and they attack our bodies in a variety of ways, as well, including through the production of toxins that ...

Lumos’s FebriDx included in Australian trial aimed at reducing unnecessary antibiotic prescribing for respiratory infections in primary care FebriDx tests one of a suite of interventions being ...